Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches

被引:37
作者
Aguilar-Gallardo, Cristobal [2 ]
Cecilia Rutledge, Emily [2 ]
Martinez-Arroyo, Ana M. [2 ]
Jose Hidalgo, Juan [3 ]
Domingo, Santiago [3 ]
Simon, Carlos [1 ,2 ]
机构
[1] Univ Valencia, Fdn IVI, Inst Univ IVI, E-46012 Valencia, Spain
[2] Prince Felipe Res Ctr CIPF, Valencia Node Spanish Stem Cell Bank, Valencia, Spain
[3] Univ Hosp La Fe, Valencia, Spain
关键词
Ovarian cancer stem cells; Microenvironment; New therapeutic approaches; ACTIVATED-RECEPTOR-GAMMA; HEPATOCELLULAR-CARCINOMA CELLS; EPITHELIAL OVARIAN; PANCREATIC-CANCER; INITIATING CELLS; PROSPECTIVE IDENTIFICATION; PROGNOSTIC MARKER; DRUG-RESISTANCE; DNA-REPAIR; STAGE-III;
D O I
10.1007/s12015-011-9344-5
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Understanding the genetic and molecular mechanisms of ovarian cancer has been the focus of research efforts working toward the greater goal of improving cancer therapy for patients with residual disease after initial treatment with conventional surgery and neoadjuvant chemotherapy. The focus of this review will be centered on new therapeutic strategies based on Cancer Stem Cells studies of chemoresistant subpopulations, the prevention of metastasis, and individualized therapy in order to find the most successful combination of treatments to effectively treat human ovarian cancer. We reviewed recent literature (1993-2011) of novel treatment approaches to ovarian cancer stem cells. As the focus of ovarian cancer investigation has centered on the cancer stem cell model and the complexities that it presents in the development of effective treatments, the future of treating ovarian cancer lies in utilizing individualized treatment systems that include enhancing existing treatments, aiming for novel therapy targets, managing the plasticity of stem cells to induce cellular differentiation, and regulating oncogenic signaling pathways.
引用
收藏
页码:994 / 1010
页数:17
相关论文
共 174 条
[71]   Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission [J].
Hirsch, Heather A. ;
Iliopoulos, Dimitrios ;
Tsichlis, Philip N. ;
Struhl, Kevin .
CANCER RESEARCH, 2009, 69 (19) :7507-7511
[72]  
Holland CM, 2004, MOL CANCER THER, V3, P993
[73]   CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells [J].
Hong, Sung Pil ;
Wen, Jing ;
Bang, Seungmin ;
Park, Seungwoo ;
Song, Si Young .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) :2323-2331
[74]   Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer [J].
Horst, David ;
Kriegl, Lydia ;
Engel, Jutta ;
Kirchner, Thomas ;
Jung, Andreas .
CANCER INVESTIGATION, 2009, 27 (08) :844-850
[75]   Clinical significance of side population in ovarian cancer cells [J].
Hosonuma, Shinji ;
Kobayashi, Yoichi ;
Kojo, Satoshi ;
Wada, Haruka ;
Seino, Ken-ichiro ;
Kiguchi, Kazushige ;
Ishizuka, Bunpei .
HUMAN CELL, 2011, 24 (01) :9-12
[76]   Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant [J].
Hu, L. ;
McArthur, C. ;
Jaffe, R. B. .
BRITISH JOURNAL OF CANCER, 2010, 102 (08) :1276-1283
[77]   A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer [J].
Hu, Xiaoxia ;
Macdonald, Dusten M. ;
Huettner, Phyllis C. ;
Feng, Zhihui ;
El Naqa, Issam M. ;
Schwarz, Julie K. ;
Mutch, David G. ;
Grigsby, Perry W. ;
Powell, Simon N. ;
Wang, Xiaowei .
GYNECOLOGIC ONCOLOGY, 2009, 114 (03) :457-464
[78]   Cancer stem cells and chemoradiation resistance [J].
Ishii, Hideshi ;
Iwatsuki, Masaaki ;
Ieta, Keisuke ;
Ohta, Daisuke ;
Haraguchi, Naotsugu ;
Mimori, Koshi ;
Mori, Masaki .
CANCER SCIENCE, 2008, 99 (10) :1871-1877
[79]   Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate [J].
Jiang, Xiaoyan ;
Forrest, Donna ;
Nicolini, Franck ;
Turhan, Ali ;
Guilhot, Joelle ;
Yip, Calvin ;
Holyoake, Tessa ;
Jorgensen, Heather ;
Lambie, Karen ;
Saw, Kyi Min ;
Pang, Emily ;
Vukovic, Ranko ;
Lehn, Paeta ;
Ringrose, Ashley ;
Yu, Miao ;
Brinkman, Ryan R. ;
Smith, Clay ;
Eaves, Allen ;
Eaves, Connie .
BLOOD, 2010, 116 (12) :2112-2121
[80]   Cancer stem cells: Are we missing the target? [J].
Jones, RJ ;
Matsui, WH ;
Smith, BD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08) :583-585